GE HealthCare Technologies (NASDAQ:GEHC) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPS

GE HealthCare Technologies (NASDAQ:GEHC) issued its earnings results on Thursday. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19, Zacks reports. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies updated its FY 2025 guidance to 4.610-4.750 EPS.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded up $7.98 on Thursday, reaching $93.88. 3,839,155 shares of the stock were exchanged, compared to its average volume of 2,678,737. The firm has a market capitalization of $42.89 billion, a PE ratio of 25.81, a PEG ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies has a 1-year low of $74.51 and a 1-year high of $94.80. The business has a fifty day moving average price of $83.58 and a two-hundred day moving average price of $85.39. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $96.77.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.